Amyloid β-Protein (Human, 1-38)

Documents

Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly
: (Trifluoroacetate Form)
: (M.W. 4131.5) C₁₈₄H₂₇₇N₅₁O₅₆S
: Endogenous Form of Amyloid β-Protein in Cerebrospinal Fluid

Package	Price(Yen)	Availability
Vial 0.5 mg	17,000	Ships within 1-3 business days
Bulk Request

Solubility: 0.1% NH₄OH or DMSO (1 mM)

M.P. Mattson, B. Cheng, D. Davis, K. Bryant, I. Lieberburg, and R.E. Rydel, J. Neurosci., 12, 376 (1992). (Pharmacol.; Enhancement of Glutamate Neurotoxicity)
J.M. Maler, H.-W. Klafki, S. Paul, P. Spitzer, T.W. Groemer, A.W. Henkel, H. Esselmann, P. Lewczuk, J. Kornhuber, and J. Wiltfang, Proteomics, 7, 3815 (2007). (Quantitation in Human Plasma)
M.E. Lame, E.E. Chambers, and M. Blatnik, Anal. Biochem., 419, 133 (2011). (Quantitation in Human Cerebrospinal Fluid)

Data Sheet